We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
-0.72%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$16.7B
AUM Growth
-$332M
Cap. Flow
-$57.8M
Cap. Flow %
-0.35%
Top 10 Hldgs %
17.41%
Holding
2,287
New
114
Increased
795
Reduced
1,162
Closed
171
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INVX
1351
Innovex International
INVX
$1.97B
$1.14M 0.01%
45,287
+6,700
+17% +$178K
CHT icon
1352
Chunghwa Telecom
CHT
$33B
$1.14M 0.01%
28,967
+8,073
+39% +$330K
UNVR
1353
DELISTED
Univar Solutions Inc.
UNVR
$1.14M 0.01%
47,771
-39,597
-45% -$936K
CCMP
1354
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$1.14M 0.01%
9,225
+118
+1% +$15.7K
CHCO icon
1355
City Holding Co
CHCO
$2.04B
$1.14M 0.01%
14,583
+1
+0% +$76
VRM icon
1356
Vroom Inc
VRM
$48.2M
$1.13M 0.01%
640
+144
+29% +$367K
CG icon
1357
Carlyle Group
CG
$17.2B
$1.13M 0.01%
23,890
-1,125
-4% -$53.9K
EXD
1358
DELISTED
Eaton Vance TaxManaged Buy-Write Strategy Fund
EXD
$1.13M 0.01%
99,875
-5,492
-5% -$65.1K
KYN icon
1359
Kayne Anderson Energy Infrastructure Fund
KYN
$2.4B
$1.13M 0.01%
140,664
+7,265
+5% +$58K
PAI
1360
Western Asset Investment Grade Income Fund
PAI
$114M
$1.12M 0.01%
71,474
-3,853
-5% -$61.2K
KRTX
1361
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$1.11M 0.01%
9,109
-212
-2% -$24.5K
LDP icon
1362
Cohen & Steers Duration Preferred & Income Fund
LDP
$600M
$1.11M 0.01%
40,541
-3,270
-7% -$88.8K
OLLI icon
1363
Ollie's Bargain Outlet
OLLI
$4.94B
$1.1M 0.01%
18,313
-640
-3% -$51.8K
HELE icon
1364
Helen of Troy
HELE
$693M
$1.1M 0.01%
4,905
+71
+1% +$16.3K
INSI
1365
DELISTED
Insight Select Income Fund
INSI
$1.1M 0.01%
52,281
+1,128
+2% +$24.5K
WYNN icon
1366
Wynn Resorts
WYNN
$10.6B
$1.1M 0.01%
12,934
-2,122
-14% -$209K
VGR
1367
DELISTED
Vector Group Ltd.
VGR
$1.09M 0.01%
120,971
-38,411
-24% -$375K
CABO icon
1368
Cable One
CABO
$212M
$1.09M 0.01%
603
-1,133
-65% -$2.22M
SYNA icon
1369
Synaptics
SYNA
$4.15B
$1.09M 0.01%
6,068
-4,223
-41% -$710K
FHI icon
1370
Federated Hermes
FHI
$4.72B
$1.09M 0.01%
33,467
+553
+2% +$18K
GBT
1371
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1.09M 0.01%
42,692
+5,170
+14% +$152K
PPLT
1372
abrdn Physical Platinum Shares ETF
PPLT
$2.02B
$1.08M 0.01%
120,160
-42,290
-26% -$403K
WOLF icon
1373
Wolfspeed
WOLF
$1.71B
$1.08M 0.01%
13,377
+969
+8% +$86.1K
NUW icon
1374
Nuveen AMT-Free Municipal Value Fund
NUW
$252M
$1.07M 0.01%
63,007
-31,367
-33% -$538K
MHF
1375
Western Asset Municipal High Income Fund
MHF
$153M
$1.07M 0.01%
134,841
-758
-0.6% -$6.2K

Similar funds

Guggenheim Capital's Q3 2021 Portfolio in Review

As of Q3 2021, Guggenheim Capital held 2,287 positions worth $16.7B, down 2% from $17B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Guggenheim Capital's Q3 2021 filing shows 114 new, 795 increased, 1,162 reduced and 171 closed positions. Its largest new stake was Logistics Innovation Technologies Corp. Class A Common Stock: 4,000,000 shares worth $38.6M. The largest sale was Alexion Pharmaceuticals, an estimated $41.8M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Guggenheim Capital's largest Q3 2021 buy was Logistics Innovation Technologies Corp. Class A Common Stock: 4,000,000 shares worth $38.6M.
  • Guggenheim Capital added most to iShares Core US Aggregate Bond ETF in Q3 2021, an estimated $50M increase.
  • Guggenheim Capital's biggest Q3 2021 reduction was Matterport, Inc. Class A Common Stock, cutting an estimated $32.4M.
  • Guggenheim Capital fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $41.8M.
  • Guggenheim Capital's ten largest holdings make up 17% of its $16.7B portfolio in Q3 2021.
  • Guggenheim Capital opened 114 new positions and closed 171 in Q3 2021.
  • Guggenheim Capital's portfolio value fell 2% quarter-over-quarter to $16.7B.

Based on Guggenheim Capital's 13F filing for Q3 2021, filed 15 Nov 2021.